
Emcure Pharmaceuticals Limited has appointed industry veteran Brijendra Singh as its new Executive Vice President, marking a significant addition to the company’s leadership team.
Singh brings over 40 years of experience in the pharmaceutical sector, with a strong track record in sales leadership, product launches, market strategy, P&L management, and expanding access to essential healthcare solutions in India and globally.
He currently serves as Vertical Head & Vice President – Sales & Marketing for the Cardiology, Diabetes, Metabolic, and Ophthalmology divisions at Lupin Limited, one of the world’s leading multinational pharmaceutical companies. Over the years, he has played a pivotal role in building and mentoring teams, driving the successful development, launch, and market expansion of critical and chronic-care therapies.
Singh’s core expertise spans strategy, pharma marketing, business development, product management, and leadership, making him a valuable asset as Emcure strengthens its portfolio and commercial operations.
Also Read
Host or sponsor events that place your brand at the forefront of healthcare impact.
Engage a wider audience with thought leadership shared across VOH's podcast channels.
Take center stage at healthcare forums to spark conversations and share bold perspectives.
Host or sponsor events that place your brand at the forefront of healthcare impact.
Engage a wider audience with thought leadership shared across VOH's podcast channels.
Take center stage at healthcare forums to spark conversations and share bold perspectives.